Total Payments
$2,325
2024 Payments
$341.48
Companies
24
Transactions
163
Medicare Patients
814
Medicare Billing
$59,172
Payment Breakdown by Category
Food & Beverage$2,325 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,325 | 163 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $456.86 | 53 | $0 (2023) |
| ABBVIE INC. | $418.10 | 25 | $0 (2023) |
| Inspire Medical Systems, Inc. | $334.51 | 5 | $0 (2024) |
| Novo Nordisk Inc | $203.06 | 23 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $155.28 | 12 | $0 (2022) |
| GlaxoSmithKline, LLC. | $117.55 | 8 | $0 (2023) |
| Lilly USA, LLC | $101.38 | 7 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $73.20 | 4 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $69.19 | 4 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $60.11 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $341.48 | 5 | Inspire Medical Systems, Inc. ($307.90) |
| 2023 | $380.85 | 18 | Supernus Pharmaceuticals, Inc. ($147.54) |
| 2022 | $841.14 | 65 | ABBVIE INC. ($228.76) |
| 2021 | $761.97 | 75 | Supernus Pharmaceuticals, Inc. ($177.95) |
All Payment Transactions
163 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $33.58 | General |
| Category: NEUROLOGY | ||||||
| 10/25/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $66.51 | General |
| Category: NEUROLOGY | ||||||
| 10/24/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $177.46 | General |
| Category: NEUROLOGY | ||||||
| 10/21/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: NEUROLOGY | ||||||
| 04/13/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $35.23 | General |
| Category: NEUROLOGY | ||||||
| 09/19/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | In-kind items and services | $124.10 | General |
| Category: PSYCHOLOGY | ||||||
| 07/26/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Diabetes | ||||||
| 05/22/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $4.45 | General |
| Category: PSYCHOLOGY | ||||||
| 05/09/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $4.38 | General |
| Category: PSYCHOLOGY | ||||||
| 05/05/2023 | SANOFI PASTEUR INC. | VAXELIS (Biological) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Vaccines | ||||||
| 04/12/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $2.07 | General |
| Category: PSYCHOLOGY | ||||||
| 04/11/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: NEUROLOGY | ||||||
| 04/10/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $5.86 | General |
| Category: PSYCHOLOGY | ||||||
| 04/05/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $6.68 | General |
| Category: PSYCHOLOGY | ||||||
| 03/21/2023 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $13.13 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 03/15/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: NEUROSCIENCE | ||||||
| 03/14/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: PSYCHIATRY | ||||||
| 03/08/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Diabetes | ||||||
| 03/01/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: NEUROSCIENCE | ||||||
| 03/01/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: VACCINES | ||||||
| 02/08/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Gastroenterology | ||||||
| 01/03/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: Endocrinology | ||||||
| 12/31/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $9.06 | General |
| Category: PSYCHOLOGY | ||||||
| 12/27/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $2.51 | General |
| Category: PSYCHOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 119 | 152 | $32,138 | $8,925 |
| 2022 | 6 | 219 | 294 | $57,657 | $17,049 |
| 2021 | 7 | 262 | 321 | $44,696 | $18,625 |
| 2020 | 6 | 214 | 230 | $36,311 | $14,573 |
Total Patients
814
Total Services
997
Medicare Billing
$59,172
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 52 | $13,000 | $3,588 | 27.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 27 | 27 | $5,998 | $2,821 | 47.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 73 | $13,140 | $2,516 | 19.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 91 | $22,750 | $5,802 | 25.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 49 | 49 | $9,898 | $5,092 | 51.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 80 | 117 | $21,060 | $4,704 | 22.3% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 12 | 13 | $754.00 | $741.24 | 98.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 13 | $533.00 | $355.63 | 66.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $2,662 | $354.20 | 13.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 55 | 55 | $11,110 | $5,844 | 52.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 51 | 78 | $15,413 | $5,445 | 35.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 66 | 88 | $12,006 | $4,144 | 34.5% |
| 90682 | Vaccine for influenza derived from dna for injection into muscle, quadrivalent, preservative and antibiotic free | Office | 2021 | 23 | 23 | $1,334 | $1,334 | 100.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 31 | 41 | $3,435 | $1,288 | 37.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 23 | 23 | $943.00 | $364.13 | 38.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 13 | 13 | $455.00 | $205.87 | 45.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 59 | 59 | $11,918 | $5,510 | 46.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 54 | 63 | $11,907 | $3,768 | 31.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 13 | 13 | $4,290 | $1,786 | 41.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 39 | 46 | $5,796 | $1,762 | 30.4% |
| 90682 | Vaccine for influenza for injection into muscle | Office | 2020 | 23 | 23 | $1,334 | $1,334 | 100.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 26 | 26 | $1,066 | $411.98 | 38.6% |
About Kerri Dexter, FNP-C
Kerri Dexter, FNP-C is a Registered Nurse healthcare provider based in Lafayette, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/03/2019. The National Provider Identifier (NPI) number assigned to this provider is 1528616513.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kerri Dexter, FNP-C has received a total of $2,325 in payments from pharmaceutical and medical device companies, with $341.48 received in 2024. These payments were reported across 163 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,325).
As a Medicare-enrolled provider, Dexter has provided services to 814 Medicare beneficiaries, totaling 997 services with total Medicare billing of $59,172. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Critical Care Medicine, Family
- Location Lafayette, IN
- Active Since 09/03/2019
- Last Updated 09/08/2023
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1528616513
Products in Payments
- QELBREE (Drug) $397.78
- INSPIRE (Device) $334.51
- VRAYLAR (Drug) $196.56
- UBRELVY (Drug) $185.94
- BREZTRI (Drug) $144.05
- Ozempic (Drug) $120.74
- TRULICITY (Drug) $75.02
- XARELTO (Drug) $73.20
- TRELEGY ELLIPTA (Drug) $72.44
- REXULTI (Drug) $52.09
- Rybelsus (Drug) $51.69
- JARDIANCE (Drug) $43.17
- QULIPTA (Drug) $35.60
- Kerendia (Drug) $34.69
- XYWAV (Drug) $33.58
- SHINGRIX (Biological) $32.45
- Dexcom G6 Transmitter (Medical Supply) $29.28
- OXTELLAR XR (Drug) $28.84
- XIFAXAN (Drug) $26.99
- TROKENDI XR (Drug) $26.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Lafayette
Kellie West, Np, NP
Registered Nurse — Payments: $5,244
Registered Nurse $5,244
Cacia Wilson
Registered Nurse — Payments: $2,669
Registered Nurse $2,669
Dr. Tera Hornbeck, Dnp, Rn, Agcns-Bc, DNP, RN, AGCNS-BC
Registered Nurse — Payments: $1,689
Registered Nurse $1,689
Ms. Megan Moriarty, Pmhnp-Bc, PMHNP-BC
Registered Nurse — Payments: $1,249
Registered Nurse $1,249
Mrs. Jennifer Schabel, Agpcnp, AGPCNP
Registered Nurse — Payments: $1,233
Registered Nurse $1,233
Matthew Thomas, Np, NP
Registered Nurse — Payments: $1,200
Registered Nurse $1,200